NP Allies Return to NPA Main Site

Treatment overview

Transcranial Magnetic Stimulation (TMS)

Transcranial Magnetic Stimulation uses focused magnetic pulses delivered through a coil placed on the scalp to induce small electrical currents in targeted brain regions. A typical depression course involves daily sessions of about 20–40 minutes five days a week for four to six weeks.

Overview

What It Is Transcranial Magnetic Stimulation (TMS) uses focused magnetic pulses from a coil placed on the scalp to change activity in targeted brain regions without surgery. In clinical practice, treatment is almost always repetitive TMS (rTMS)—many pulses delivered in a session—sometimes using protocol variants such as intermittent theta-burst stimulation (iTBS) or deep TMS (a different coil that reaches broader areas). A typical depression course is daily sessions over several weeks.

How It Works Magnetic pulses induce small electrical currents in cortex under the coil. Depending on frequency and pattern, stimulation can increase or decrease local excitability and influence connected networks involved in mood, pain, or motor control. Repeated sessions are thought to support lasting network changes—an externally driven form of plasticity. Effects depend on target, dose, and diagnosis.

On-label / FDA-cleared uses (examples; device- and protocol-specific) - Major depressive disorder (including treatment-resistant depression) — the most established clinical use of rTMS - Certain protocols/devices cleared for obsessive-compulsive disorder (OCD) - Some systems cleared for migraine with aura (as a short-term treatment option) - Always confirm the specific device’s labeled indications

Off-label / investigational uses - PTSD, anxiety disorders, chronic pain, Parkinson’s symptoms, post-stroke motor or language recovery, cognitive symptoms, and other neurologic/psychiatric targets under research or individual clinical judgment - Evidence quality varies widely by indication; these uses are not first-line standard care in most settings

Types you will hear about - rTMS — standard clinical repetitive protocols (including for depression) - iTBS — shorter theta-burst sessions, increasingly used for depression - Deep TMS — H-coil systems for broader/deeper stimulation; labeled uses depend on the system - Research TMS in motor mapping or paired with rehab (investigational combinations)

How it is administered

Outpatient clinic sessions. A coil is positioned on the scalp; you remain awake. Depression protocols often involve sessions 5 days per week for about 4–6 weeks (iTBS sessions are shorter). A technician or clinician operates the device; psychiatry or neurology teams oversee care.

The NPA Treatment Database lists this treatment in connection with 7 condition records. A database relationship does not establish effectiveness, safety, or suitability for an individual.

These controlled question pages reference this treatment through stored condition relationships.

Symptoms connected in the NPA database

The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.

Cognition & Memory

  • Difficulty concentrating
  • Difficulty concentrating (“brain fog”)
  • indecisiveness
  • Later memory and thinking changes
  • memory complaints
  • Memory gaps related to trauma
  • mental fog during/after attacks
  • negative beliefs
  • racing thoughts
  • Short-term memory problems
  • slowed mental processing
  • slowed thinking
  • spatial neglect
  • worry

Emotion & Behavior

  • anxiety
  • apathy
  • avoidance
  • avoidance behaviors
  • depression
  • emotional lability (uncontrollable laughing/crying)
  • emotional numbness
  • Excessive fear or worry
  • feelings of worthlessness
  • frustration
  • Intrusive memories/flashbacks
  • irritability
  • loss of interest/pleasure
  • mood changes
  • mood changes before or during attacks
  • Persistent sadness
  • social withdrawal

Motor Control

  • balance and gait problems
  • difficulty walking
  • exaggerated startle response
  • guarding
  • Hyperarousal
  • muscle stiffness/spasticity
  • muscle tension
  • Occasional weakness or coordination changes during aura (rare subtypes)
  • One-sided weakness or paralysis
  • poor balance and coordination
  • Reduced mobility
  • Restlessness
  • rigidity/stiffness
  • slowed movement (bradykinesia)
  • Slowed movements or restlessness (psychomotor changes)
  • trembling
  • Tremor

Sensory & Pain

  • central post-stroke pain (burning, shooting pain, and sensitivity to touch, temperature)
  • headaches
  • heightened bodily awareness
  • heightened sensitivity
  • muscle aches
  • nausea
  • Numbness or altered sensation
  • Pain
  • Persistent pain (aching, burning, stabbing)
  • Physical reactions to triggers
  • Physical sensations (heart racing, chest tightness, sweating)
  • reduced sense of smell
  • sensitivity to light/sound/smell
  • sensory changes
  • Throbbing or pulsing head pain
  • Unexplained aches and pains

Sleep & Fatigue

  • Excessive fatigue
  • fatigue
  • insomnia
  • Insomnia or hypersomnia
  • Nightmares
  • post-attack exhaustion
  • profound fatigue and low energy
  • sleep disruption
  • Sleep disruption due to pain
  • sleep disturbances
  • Sleep problems (including REM sleep behavior disorder)
  • Trouble falling or staying asleep

Practical information

Insurance coverage

Often covered for FDA-cleared depression indications when prior-authorization criteria are met (e.g., adequate medication trials). Coverage for OCD or migraine depends on plan and device labeling. Off-label uses are frequently not covered.

Cost information

Per-course costs are high before insurance (often thousands of dollars for a full depression series); covered care reduces patient responsibility to plan copays/coinsurance.

Results and outcomes described in the source record

For depression, many people notice mood changes during the treatment course or within weeks after; full response is assessed at the end of the acute series. Other indications follow different timelines.

Side effects and risks

Generally well tolerated. Common effects: scalp discomfort or headache during/after sessions. Seizure risk is low but real; screening for contraindications (e.g., certain metal implants, seizure history) is required. Hearing protection is used because of coil noise.

Research context in the NPA database

This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.

Research summary

Evidence Level: Strong (for major depression with rTMS); Moderate for some cleared OCD/migraine protocols; Emerging to limited for most off-label neurologic uses What the research shows: Multiple trials and meta-analyses support rTMS for treatment-resistant major depression. OCD and selected migraine indications have device-specific supporting data. Stroke, pain, Parkinson’s, and PTSD applications remain active research areas with mixed results. Key takeaway: An established non-invasive brain-stimulation option for depression; other uses should be framed carefully as cleared vs investigational.

Research detail

Overview TMS delivers magnetic pulses to modulate targeted brain regions. Clinical care uses repetitive protocols (rTMS, including iTBS and deep TMS variants), with the strongest evidence and coverage for major depression.

Evidence Base and Published Work • Major depression: robust evidence base for rTMS as an augmentation or alternative when medications are insufficient. • OCD and migraine: selected devices/protocols have regulatory clearance supported by clinical studies. • Neurologic applications (stroke motor recovery, pain, Parkinson’s, cognitive symptoms): promising studies but not uniform standard of care; often off-label. • Safety literature supports a favorable profile when screening and dosing guidelines are followed.

Outcomes Outcomes most frequently described for depression include meaningful symptom reduction in a substantial subset of patients after a full acute course, with maintenance strategies varying. Other indications show more variable response rates.

Questions to ask a provider

1. Is TMS appropriate for my treatment-resistant depression (or other indication), and which protocol (standard, theta-burst, accelerated) do you recommend? 2. How many sessions are required, and what is the daily/weekly schedule? 3. What response and remission rates are typical for patients with a history like mine? 4. What side effects should I expect (scalp discomfort, headache), and what is the seizure risk after screening? 5. Is TMS covered by my insurance for this indication, and what prior authorization is needed?

Explore the interactive Treatment Database

Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.

Explore treatment information in the database

Educational information disclaimer

The information provided in this app is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment, and should not be relied upon as a substitute for professional medical care.

Treatments, therapies, and interventions described here may not be appropriate for every person or condition. Evidence levels, availability, costs, insurance coverage, and risks can vary. Nothing in this app constitutes a recommendation that you start, stop, or change any treatment.

Always consult your physician, neurologist, or other qualified healthcare provider before beginning any new therapy, device, program, or intervention, and before making decisions about your care. Seek prompt medical attention for any urgent or emergency symptoms. By using this app, you acknowledge that NP Allies and its contributors are not responsible for any decisions you make based on the information provided, or for any outcomes that result from those decisions.